Impact of irinotecan and oxaliplatin on overall survival in patients with metastatic colorectal cancer: a population-based study.

Lim, Howard J; Gill, Sharlene; Speers, Caroline; Melosky, Barbara; Barnett, Jeff; Fitzgerald, Catherine; O'Reilly, Susan; Kennecke, Hagen

Lim, Howard J; Gill, Sharlene; Speers, Caroline; Melosky, Barbara; Barnett, Jeff; Fitzgerald, Catherine; O'Reilly, Susan; Kennecke, Hagen.

Afiliação

Lim HJ; Division of Medical Oncology; and Population and Preventive Oncology, British Columbia Cancer Agency, Vancouver; and Division of Medical Oncology, British Columbia Cancer Agency, Victoria, British Columbia, Canada.

J Oncol Pract ; 5(4): 153-8, 2009 Jul.

Article em En | MEDLINE | ID: mdl-20856627

ABSTRACT

ABSTRACT

A look at the temporal impact of advancements in therapeutic options in the last 10 years-from fluorouracil to irinotecan and oxaliplatin-on overall survival in a population-based cohort.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2009 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2009 Tipo de documento: Article